Table 3.

Patient characteristics stratified according to low and high extent of LGE

	Low (≤25.3%) LGE (n = 41)	High (>25.3%) LGE (n = 41)	P-value
Age, years	59 ± 10	61 ± 7	0.42
BSA (Mosteller)*	2.1 ± 0.2	2.0 ± 0.2	0.15
CHA2DS2-VASc score	1.1 ± 1.2	1.3 ± 1.1	0.50
Hypertension	9 (22%)	18 (44%)	0.03
Diabetes mellitus	2 (5%)	2 (5%)	1.00
LA volume index—max (ml/m2)	48 ± 12	51 ± 16	0.36
LA sphericity (%)	79.7 ± 2.8	79.3 ± 3.3	0.61
LA function volumetric
Total LAEF (%)	55 ± 11	50 ± 15	0.09
Passive LAEF (%)	29 ± 11	24 ± 9	0.03
Active LAEF (%)	25 ± 9	25 ± 11	0.98
LA strain
LA reservoir strain (%)	− 16.9 ± 3.3	− 15.0 ± 3.9	0.02
LA conduit strain (%)	− 9.5 ± 2.6	− 7.9 ± 2.7	0.01
LA contractile strain (%)	− 7.4 ± 2.4	− 7.1 ± 2.3	0.55
LA peak positive strain rate	0.76 ± 0.27	0.70 ± 0.22	0.36
LA peak early negative strain rate	− 0.89 ± 0.31	− 0.76 ± 0.35	0.08
LA peak late negative strain rate	− 0.88 ± 0.28	− 0.80 ± 0.33	0.22
LA reservoir strain time (ms)	396 ± 51	383 ± 41	0.22
LA conduit strain time (ms)	452 ± 133	410 ± 130	0.15
LA contractile strain time (ms)	137 ± 35	132 ± 31	0.51

Values are expressed as number (percentage) or mean ± SD. BMI body mass index, BSA body surface area, CHA2DS2VASc history of congestive heart failure, hypertension, diabetes mellitus, stroke/transient ischemic attack/prior thromboembolism, vascular disease, age and sex, LA left atrium, LAEF left atrial emptying fraction, LGE late gadolinium enhancement. Bold values denote statistical significance at the P < 0.05 level

*Calculated by the Mosteller method ((height (cm) x weight (kg)/3600)^½)